Symposium on membrane transport. Transport in the central nervous system.
作者信息
Davson H, Oldendorf W H
出版信息
Proc R Soc Med. 1967 Apr;60(4):326-9. doi: 10.1177/003591576706000405.
Abstract
摘要
相似文献
1
Symposium on membrane transport. Transport in the central nervous system.
Proc R Soc Med. 1967 Apr;60(4):326-9. doi: 10.1177/003591576706000405.
2
[Present status of physiological research of the hemato-encephalic barrier].
Cesk Fysiol. 1968 Oct;17(4):365-70.
3
Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.
Pharmacol Rev. 2001 Dec;53(4):569-96.
4
Kinetics of water-soluble contrast media in the central nervous system.
AJR Am J Roentgenol. 1983 Oct;141(4):815-24. doi: 10.2214/ajr.141.4.815.
5
Peptide and peptide analog transport systems at the blood-CSF barrier.
Adv Drug Deliv Rev. 2004 Oct 14;56(12):1765-91. doi: 10.1016/j.addr.2004.07.008.
6
[The blood-brain barrier. II. Physiological data].
Rev Neurol (Paris). 1984;140(1):3-13.
7
Transport through the ependymal linings.
Prog Brain Res. 1968;29:159-72. doi: 10.1016/S0079-6123(08)64154-0.
8
Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
Adv Drug Deliv Rev. 2004 Oct 14;56(12):1717-40. doi: 10.1016/j.addr.2004.07.006.
9
The fluid exchange of the central nervous system.
Symp Soc Exp Biol. 1965;19:349-64.
10
Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
J Cereb Blood Flow Metab. 2000 Jan;20(1):168-74. doi: 10.1097/00004647-200001000-00021.
引用本文的文献
1
Endothelial Neurogranin Regulates Blood-Brain Barrier Permeability via Modulation of the AKT Pathway.
Mol Neurobiol. 2025 Apr;62(4):3991-4007. doi: 10.1007/s12035-024-04522-9. Epub 2024 Oct 5.
2
From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease.
J Neurochem. 2025 Jan;169(1):e16219. doi: 10.1111/jnc.16219. Epub 2024 Sep 10.
3
Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review).
Int J Oncol. 2021 Jun;58(6). doi: 10.3892/ijo.2021.5215. Epub 2021 May 6.
4
Astrocyte Activation in Neurovascular Damage and Repair Following Ischaemic Stroke.
Int J Mol Sci. 2021 Apr 20;22(8):4280. doi: 10.3390/ijms22084280.
5
Basic physiology of the blood-brain barrier in health and disease: a brief overview.
Tissue Barriers. 2021 Jan 2;9(1):1840913. doi: 10.1080/21688370.2020.1840913. Epub 2020 Nov 15.
6
Increased activity of the complement system in cerebrospinal fluid of the patients with Non-HIV Cryptococcal meningitis.
BMC Infect Dis. 2017 Jan 4;17(1):7. doi: 10.1186/s12879-016-2107-9.
7
Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders.
Int J Mol Sci. 2016 Mar 4;17(3):338. doi: 10.3390/ijms17030338.
8
Computational and Pharmacological Target of Neurovascular Unit for Drug Design and Delivery.
Biomed Res Int. 2015;2015:731292. doi: 10.1155/2015/731292. Epub 2015 Oct 22.
9
Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives?
Front Neurosci. 2015 Oct 29;9:385. doi: 10.3389/fnins.2015.00385. eCollection 2015.
10
Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP.
Fluids Barriers CNS. 2015 Jan 24;12(1):2. doi: 10.1186/2045-8118-12-2. eCollection 2015.
Zotero 插件